切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2008, Vol. 02 ›› Issue (06) : 24 -27. doi: 10.3877/cma.j.issn.1674-0793.2008.06.011

论著

门静脉高压症脾功能亢进与正常脾组织细胞因子表达差异的研究
马双余1, 李爱民1, 李宗芳1,(), 张澍1, 蒋安1, 张健1, 周蕊1, 党双锁2   
  1. 1.710004 西安,西安交通大学医学院第二附属医院外科
    2.710004 西安,西安交通大学医学院第二附属医院感染科
  • 收稿日期:2008-10-22 出版日期:2008-12-01
  • 通信作者: 李宗芳
  • 基金资助:
    教育部新世纪优秀人才支持计划资助(NCET-04-0932)国家自然科学基金资助(30471692)教育部博士点基金资助(20040698044)

Study of differential expression of cytokines between portal hypertensive hypersplenic tissue and normal splenic tissue by protein array

Shuang-yu MA1, Ai-min LI1, Zong-fang LI1,(), Shu ZHANG1, An JIANG1, Jian ZHANG1, Rui ZHOU1, Shuang-suo DANG1   

  1. 1.Department of Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710004, China
  • Received:2008-10-22 Published:2008-12-01
  • Corresponding author: Zong-fang LI
引用本文:

马双余, 李爱民, 李宗芳, 张澍, 蒋安, 张健, 周蕊, 党双锁. 门静脉高压症脾功能亢进与正常脾组织细胞因子表达差异的研究[J/OL]. 中华普通外科学文献(电子版), 2008, 02(06): 24-27.

Shuang-yu MA, Ai-min LI, Zong-fang LI, Shu ZHANG, An JIANG, Jian ZHANG, Rui ZHOU, Shuang-suo DANG. Study of differential expression of cytokines between portal hypertensive hypersplenic tissue and normal splenic tissue by protein array[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2008, 02(06): 24-27.

目的

研究门静脉高压症(portal hypertension,PH)脾亢脾与正常脾组织细胞因子的表达差异,为进一步探讨PH脾亢的发生机制和脾亢脾的免疫功能奠定基础。

方法

正常脾组织取自脾外伤手术切除的脾脏(A组,6例),脾亢脾组织取自PH脾亢患者手术切除的脾脏(B组,14例);无菌取材后提取两组脾组织的蛋白质,用RayBio Human Cytokine Array 5.1细胞因子芯片(美国Ray生物技术公司)同时检测两组脾组织79个细胞因子的表达,得到两组细胞因子表达点阵图,用ScanAlyze图像分析软件对两组间的细胞因子表达差异进行统计学分析。

结果

79个细胞因子中,共有26个在两组间的表达呈现明显差异。在PH脾亢脾组织中表达上调的细胞因子共有21个,其中包括与单核细胞趋化和巨噬细胞活化相关的细胞因子如MCSF、TNF-β、IFN-γ、IL-10和SDF-1/CXCL12等,以及与血管新生、纤维化和组织改建相关的细胞因子如VEGF、TGF-β1、MIF、FGF-9、Flt-3、Ligand和IGFBP-2等。脾亢脾组织表达下调的细胞因子共有5个。

结论

PH脾亢脾与正常脾组织细胞因子存在明显表达差异,这些差异表达的细胞因子可能是导致PH脾脏的免疫功能变化及脾亢发生的重要因素之一,但尚需进一步研究证实。

Objective

To study the differential expression of cytokines between portal hypertensive(PH) hypersplenic tissue and normal splenic tissue, then to analyze the significance of differential expression and provide clues for deep research of the mechanisms of hypersplenism and the immunologic changes of hypersplenic spleen.

Methods

The normal splenic tissue specimens from surgical therapy for traumatic splenic rupture of healthy adults(group A)and the hypersplenic tissue specimens from surgical therapy for hypersplenism due to PH patients (group B) were collected aseptically. Extract proteins and quantify protein concentration by using BCA method.Then the RayBio Human Cytokine Array 5.1(Ray Biotech corp.USA)was used to detect the differential expression of 79 cytokines between PH hypersplenic tissue and normal splenic tissue to construct a differential expression profile,and the ScanAlyze software was used for statistical analysis.

Results

Among 79 cytokines detected,there were 26 cytokines up-regulate significantly in hypersplenic tissue compared with normal splenic tissue,most of which were cytokines associated with monocytes chemotaxis and macrophages activation,such as MCSF,TNF-β, IFN-γ, IL-10 and SDF-1/CXCL12. Further more, cytokines associated with angiogenesis, fibrosis and tissue remodeling up-regulate in PH hypersplenic tissue as well, such as VEGF, TGF-β1, MIF, FGF-9,Flt-3 Ligand and IGFBP-2. And there were 5 cytokines down-regulate in PH hypersplenic tissue.

Conclusion

There are significant differential expression profile between PH hypersplenic tissue and normal splenic tissue. The differential expression of cytokines will be associated with the immunological status of hypersplenic spleen and the developmentof hypersplenism.But the function need for deeper research.

表1 RayBio Human Cytokine Array 5.1 的细胞因子名称及位点
表2 PH 脾亢脾组织和正常脾组织差异表达的细胞
位点 简称 中英文全称 B/A比值
5G BLC/CXCL13 B淋巴细胞趋化因子(B-lymphocyte chemoattractant) 0.0029*
5F BDNF 脑源性神经生长因子(brain-derived neurotrophic factor) 0.2099*
3E MCP-1/CCL2 单核细胞趋化蛋白-1(monocyte chemoattractant protein-1) 0.2628*
2C IL-1β 白细胞介素-1β(interleukin-1β) 0.4342*
4I EGF 表皮生长因子(epidermal growth factor) 0.4959*
7C IL-16 白细胞介素-16(interleukin-16) 2.0007#
2K IL-10 白细胞介素-10(interleukin-10) 2.2129#
3I MDC/CCL22 巨噬细胞源性趋化因子(macrophage-derived chemokine) 2.6714#
4D SDF-1/CXCL12 基质细胞源性因子-1(stromal cell-derived factor-1) 2.6989#
3F MCP-2/CCL8 单核细胞趋化蛋白-2(monocyte chemoattractant protein-2) 2.8325#
8F TGF-β3 转化生长因子-β3(transforming growth factor-β3) 3.0529#
8E TGF-β2 转化生长因子-β2(transforming growth factor-β2) 3.0629#
7A IGFBP-3 胰岛素样生长因子结合蛋白-3(insulin-like growth factor binding protein-3) 3.5336#
5C VEGF 血管内皮细胞生长因子(vascular endothelial growth factor) 3.5457#
7H MIF 间皮诱导因子(mesoderm inducing factor) 3.6794#
4C SCF 干细胞因子(stem cell factor) 3.8792#
6K IGFBP-2 胰岛素样生长因子结合蛋白-2(insulin-like growth factor binding protein-2) 4.0006#
3H MCSF 巨噬细胞克隆刺激因子(macrophage colony-stimulating factor) 4.2963#
7E LIF 白血病抑制因子(leukemia inhibitory factor) 4.5701#
4H TNF-β 肿瘤坏死因子-β(tumor necrosis factor-β) 4.7776#
7F LIGHT 肿瘤坏死因子超家族14(TNF ligand superfamily member 14) 5.1996#
6D FGF-9 成纤维细胞生长因子-9(fibroblast growth factor-9) 5.3699#
6E Flt-3 Ligand fms样酪氨酸激酶-3配体(fms-like tyrosine kinase-3 Ligand) 5.5612#
4F TGF-β1 转化生长因子-β1(transforming growth factor-β1) 5.7262#
3D IFN-γ 干扰素-γ(interferon-γ) 10.8421#
7K NT-3 神经细胞生长因子-3(neurotrophin-3) 142.8749#
1
Wang YX, Li ZF, Li GW, et al. Effect of splenomegaly and splenic macrophage activity in hypersplenism due to cirrhosis. Am J Med,2002,113(5):428-431.
2
张煜,李宗芳,孙晓力,等.门静脉高压症脾功能亢进脾巨噬细胞吞噬功能的变化及其与脾亢程度的相关性.中华普通外科杂志,2005,20(2):115-116.
3
李宗芳,高君,张澍,等.门静脉高压症脾亢脾巨噬细胞数量及其吞噬功能的观察.中华实验外科杂志,2006,11(23):1288-1290.
4
Zongfang Li,Shu Zhang,Gaobo Lv,et al.Changes in Count and Function of Splenic Lymphocytes from Patients with Portal Hypertension.World Journal of Gastroenterology.2008,14(15):2377-2382.
5
Portz O, Schwenk JM, Kramer S, et al. Protein microarrays: catching the proteome.Mech Ageing Dev,2005,126(1):161-170.
6
Turtinen LW,Prall DN,Bremer LA,et al. Antibody array-generated profiles of cytokine release from THP - 1 leukemicmonocytes exposed to different amphotericin B formulations. Antimicrob Agents Chemother,2004,48(2):396-403.
7
Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism.Ann Neurol,2004,57(1):67-81.
8
Huang L, Zhao A, Wong F, et al. Leukotriene B4 strongly increases monocyte chemoattractant protein-1 in human monocytes. Arterioscl er Thromb Vasc Biol,2004,24(10):1783-1788.
9
Mantovani A, Sica A, Sozzani S, et al. The chemokine system in diverseformsofmacrophageactivationand polarization.Trends Immunol,2004,25(12):677-686.
10
Tim DE, Michelle G, Christine M,et al. M-CSF Induces Vascular Endothelial Growth Factor Production and Angiogenic Activity from Human Monocytes. The Journal of Immunology, 2003, 171(5): 26 37-2643.
11
Siamon G. Alternative activation of macrophages. Immunology, 2003,3(1):23-35.
12
Ma J,Chen T,Mandelin J,et al.Regulation of macrophage activation.Cellular and Molecular Life Sciences,2003,60(11):2334-2346.
13
Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine(MDC, CCL22) production. Crit Rev Immunol, 2002, 22(2):105-114.
14
Vulcano M, Albanesi C, Stoppacciaro A, et al. Dendritic cells as a major source of macrophage-derived chemokine/CCL22 in vitro and in vivo.Eur J Immunol,2001,31(3):812-822.
15
Li Zongfang,Zhang Shu,Huang Ying,et al.The morphological changes of blood spleen barrier in portal hypertensive spleen. Chinese Medical Journal.2008,121(6):561-565.
[1] 钱雅君, 虞竹溪, 徐颖, 董丹江, 顾勤. 危重型新型冠状病毒感染合并侵袭性肺曲霉病的临床特征和高危因素分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(01): 3-9.
[2] 王卫东. 贲门周围血管离断与左膈下静脉的保留[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 464-464.
[3] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[4] 张燕, 杨跃青, 邱峥. IgG 联合血清细胞因子对肺结核并发慢性肺曲霉菌病的诊断意义[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 809-812.
[5] 蒋丽芳, 林冰. 桑菊清解汤联合左氧氟沙星治疗社区获得性肺炎的临床分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(03): 458-461.
[6] 王飞, 陈政, 余德才, 曹亚娟. 原发性肝癌合并门静脉高压症的微创手术治疗[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 306-310.
[7] 傅红兴, 王植楷, 谢贵林, 蔡娟娟, 杨威, 严盛. 间充质干细胞促进胰岛移植效果的研究进展[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(06): 351-360.
[8] 徐嘉愉, 张复华, 牛国敏, 梁家宝, 潘焕玉, 麦秀蕖, 杨国雷, 徐嘉良, 黄佑勇. Th1/Th2细胞因子谱在恶性血液肿瘤患者化疗后中性粒细胞缺乏伴感染的应用价值[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 143-150.
[9] 阿卜杜萨拉木·图尔荪麦麦提, 吐尔洪江·吐逊, 温浩. 肝脏缺血-再灌注损伤与cGAS-STING信号通路[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 394-397.
[10] 苏日顺, 卢逸, 庄宝鼎, 张译, 李彦杰, 徐见亮. 肝硬化脾亢脾切除术后门静脉血栓形成影响因素[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(01): 39-44.
[11] 杨金涓, 夏建平. 糖尿病性黄斑水肿患者基线房水细胞因子水平评估血管内皮生长因子疗效的临床研究[J/OL]. 中华眼科医学杂志(电子版), 2023, 13(06): 350-355.
[12] 杨智钧, 谷佳, 丁聿贤, 张正奎, 于如同. 脑胶质瘤患者血清炎性因子水平与病理分级及预后的相关性[J/OL]. 中华神经创伤外科电子杂志, 2024, 10(04): 238-242.
[13] 丛黎, 马林, 陈旭, 李文文, 张亮亮, 周华亭. 改良CT严重指数联合炎症指标在重症急性胰腺炎患者胰腺感染预测及预后评估中的研究[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 432-436.
[14] 李益军, 梁兴森, 方细霞, 肖文良, 李湘, 高彦平, 李嘉, 李玲. 温针灸治疗早中期寒湿痹阻型膝骨关节炎的疗效观察[J/OL]. 中华针灸电子杂志, 2024, 13(01): 7-12.
[15] 南朝涛, 陈建, 王书鸿, 李刚, 郝俊杰. 血清细胞因子预测急性脑梗死后肺炎的价值[J/OL]. 中华卫生应急电子杂志, 2024, 10(01): 16-20.
阅读次数
全文


摘要